Factor VII Antikörper (Coagulation Factor VII)

Details for Product anti-F7 Antibody No. ABIN4264232, Anbieter: Anmelden zum Anzeigen
Antigen
  • F7
  • wu:fb59f04
  • zgc:109870
  • LOC100223776
  • AI132620
  • Cf7
  • FVII
  • mfVII
  • SPCA
  • coagulation factor VII
  • coagulation factor VII (serum prothrombin conversion accelerator)
  • F7
  • f7
  • CpipJ_CPIJ009142
  • CpipJ_CPIJ010295
  • CpipJ_CPIJ020127
  • LOC100223776
  • fa7
Reaktivität
Human
179
30
11
6
3
2
2
1
1
Wirt
Maus
103
79
25
3
1
1
Klonalität (Klon)
Monoklonal ()
Konjugat
Dieser Factor VII Antikörper ist unkonjugiert
23
10
8
5
5
4
4
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Applikation
ELISA, Radioimmunoassay (RIA), Western Blotting (WB)
150
94
30
16
16
16
13
12
11
10
8
7
4
4
3
2
2
2
1
1
1
1
1
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Immunogen Purified Factor VII
Klon RFF-VII-2
Isotyp IgG1
Spezifität VII
Reinigung Protein A or G purified
Andere Bezeichnung Coagulation Factor VII (F7 Antibody Abstract)
Hintergrund Gene Symbol: F7
Gen-ID 2155
UniProt P08709
Pathways Response to Growth Hormone Stimulus, Platelet-derived growth Factor Receptor Signaling
Applikationshinweise Western Blot 1:100-1:2000, ELISA 1:100-1:2000, Radioimmunoassay 1:100-1:2000Binds to a conformational epitope and will not bind to reduced Factor VII.
Kommentare

The antibodies are intended for use in vitro experiments only. Our antibodies have not been tested nor are recommended for use in vivo.

Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1.0 mg/mL
Buffer PBS ( pH 7.4)
Buffer contains: 0.09 % Sodium Azide
Konservierungsmittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung 4 °C,-20 °C
Informationen zur Lagerung Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Produkt verwendet in: Mahlangu, Paz, Hardtke, Aswad, Schroeder: "TRUST trial: BAY 86-6150 use in haemophilia with inhibitors and assessment for immunogenicity." in: Haemophilia : the official journal of the World Federation of Hemophilia, Vol. 22, Issue 6, pp. 873-879, 2016 (PubMed).

Haben Sie etwas anderes gesucht?